Risk and incidence of fatal adverse events associated with immune checkpoint inhibitors: a systematic review and meta-analysis
Yi Jiang,1 Ning Zhang,1 Hailin Pang,1 Xiaobo Gao,2 Helong Zhang1,3 1Department of Oncology, Tangdu Hospital, Air Force Military Medical University, Xi’an, Shan’xi, China; 2Department of Medicine, Tangdu Hospital, Air Force Military Medical University, Xi’an, Shan&rs...
Saved in:
Main Authors: | Jiang Y (Author), Zhang N (Author), Pang H (Author), Gao X (Author), Zhang H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review
by: Ling Gao, et al.
Published: (2019) -
Gender Differences in the Incidence of Adverse Cardiovascular Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Sheharyar Minhas, MD, et al.
Published: (2020) -
A model‐based meta‐analysis of immune‐related adverse events during immune checkpoint inhibitors treatment for NSCLC
by: Renwei Zhang, et al.
Published: (2022) -
Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
by: Zoe Apalla, et al.
Published: (2021) -
Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
by: Shuo Zhang, et al.
Published: (2021)